Takeda Ventures — Full Portfolio
27 tracked investments · listed companies and verified rows first
Quince Therapeutics is a biotechnology company developing the AIDE technology platform, a drug/device combination that encapsulates medications into a patient's own red blood cells to improve drug delivery for rare diseases.
BiotechSouth San Francisco, US
Stephen Dominy(Director)Casey Lynch(Executive Officer, Director)Charles Ryan(Executive Officer)inBrendan Hannah(Executive Officer)Dirk Thye(Executive Officer, Director)inKristen Gafric(Executive Officer)
Co-investorsForesite CapitalSofinnova Partners
Xilio Therapeutics is a clinical-stage biotechnology company developing masked immuno-oncology therapies that use protein engineering to remain inactive until activated by tumor-specific proteases within the tumor microenvironment.
BiotechHealthtechWaltham, US
René Russo(Executive Officer, Director)inJoseph Farmer(Executive Officer)Timothy Clackson(Executive Officer)Christopher Frankenfield(Chief Financial and Operating Officer)inKatarina Luptakova(Chief Medical Officer)inPaul Clancy(Director)
Co-investorsBain Capital Life SciencesBay City CapitalF-Prime CapitalM VenturesMRL Ventures FundRA Capital+9 more
Co-investorsAllianz XLG Technology VenturesMcKesson VenturesP5 Health VenturesPerot Jain
HealthtechSaratoga Springs, US
Daniel T. Pickett III(Executive Officer, Director)Timothy Koehler(Executive Officer)Greg Stephen(Executive Officer)
BoardHolly Benson(Director)Mary Langowski(Director)Peter Dorsman(Director)
Co-investorsClaritas CapitalWhat If VenturesOlive Tree VenturesPivotal Life SciencesVista Equity Partners
Arcellx develops CAR T-cell therapies that are individually designed for each patient, using the immune system to target and attack cancer.
BiotechHealthtechGaithersburg, US
Han Lee(Executive Officer)Rami Elghandour(Executive Officer, Director)in
BoardJill Carroll(Director)inAli Behbahani(Director)inDerek Yoon(Director)inTiba Aynechi(Director)in
Co-investorsLG Technology VenturesNew Enterprise Associates (NEA)Quan CapitalSamsara BioCapitalSixty Degree CapitalSolasta Ventures+5 more
Aspen RxHealth operates a community of pharmacists to deliver clinical pharmacy care and medication support for patients and health plan members.
Digital HealthHealthtechSaaS
Co-investorsBessemer Venture PartnersFlare Capital Partners
Biofourmis provides technology-enabled solutions and a platform for AI-driven in-home patient care, using wearable biosensors and remote monitoring to deliver and transition patients across levels of care.
AI & Machine LearningDigital HealthHealthtech
Kuldeep Singh Rajput(Founder)in
Co-investorsIntel CapitalGeneral AtlanticMassMutual VenturesOpenspace Ventures
Boulder provides medication-assisted treatment for addiction through licensed specialists who prescribe buprenorphine, supported by dedicated care teams offering medical care, peer recovery coaching, and care coordination accessible via a digital platform.
Digital HealthHealthtechMental HealthBoulder, US
Co-investorsAdvance Venture PartnersGreycroftLaerdal Million Lives FundTusk Venture Partners
Code Biotherapeutics develops a proprietary non-viral 3DNA delivery platform for genetic medicines, RNAi, and other modalities, using targeting molecules to reach specific cells and tissues outside the liver.
BiotechDeep TechHealthtechHatfield, US
Lauren Kaskiel(Executive Officer)inRobert C. Getts(Executive Officer)Brian McVeigh(Executive Officer, Director)in
BoardDmitry Kuzmin(Director)Victor Stone(Director)Edward Mathers(Director)
Co-investorsNew Enterprise Associates (NEA)4BIO CapitalAmgen VenturesHatteras Venture PartnersJDRF T1D FundNorthpond Ventures+1 more
Ensoma is a genomic medicine company developing a platform for in vivo engineering of hematopoietic stem cells (HSCs), combining an off-the-shelf delivery system with a gene engineering toolkit intended to treat diseases with a one-time treatment.
BiotechHealthtechMedical DevicesBoston, US
Albert Seymour(Director)
BoardKush Parmar(Executive Officer, Director)inPaula Soteropoulos(Director)Stephen Knight(Director)in
Co-investors5AM VenturesAju IB Invesment CorporationCatalio Capital Management, LPDelos CapitalF-Prime CapitalSolasta Ventures+7 more
Enzyre develops a handheld diagnostic device that performs multiple blood coagulation assays in parallel to identify bleeding causes at the point of care.
BiotechDeep TechDigital HealthHealthtechMedical DevicesEindhoven, NL
Wim van den Broek(CEO)inWaander(CSO)
Co-investorsNovalis Biotechi&i Biotech FundOost NL
Cambridge, MA biotech developing engineered tRNA "protein editing" therapeutics for nonsense-mutation diseases; reported shut down in 2025.
Cambridge, US
Leslie J Williams(Executive Officer, Director)
BoardBenjamin Chen(Director)Seiji Miyahara(Director)inSacha Mann(Director)David Moskowitz(Director)Steven Gillis(Director)in
Co-investorsARCH Venture Partners8VCTaiho Ventures, LLC
ISHI offers a discharge transitions program that manages patient recovery during the post-hospital period with personalized care coordination and clinical insights for care teams and healthcare administrators.
AI & Machine LearningDigital HealthHealthtech
Dr. Ajay Srivastava(Founder)
Clinical-stage immuno-oncology company developing antibodies derived from the immune systems of 'Elite' cancer responders.
BiotechHouston, US
Alice Bexon(Executive Officer)inClifford J. Stocks(Director, Executive Officer)inKamal D. Puri(Executive Officer)inChris Russell(Executive Officer)inRuss Hawkinson(Executive Officer)
BoardSteven Gillis(Director)in
Co-investors3B Future Health FundCanaan PartnersGreatPoint VenturesRiverVest Venture PartnersARCH Venture PartnersBering Capital+3 more
Oshi provides virtual gastrointestinal care delivered by gastroenterologists, dietitians, and gut-brain specialists to patients seeking treatment for GI conditions.
Digital HealthHealthtech
Sam Holliday(CEO)in
Co-investorsBessemer Venture PartnersCVS Health VenturesFlare Capital PartnersFrist Cressey VenturesKoch Disruptive TechnologiesOak HC/FT+1 more
BiotechWaltham, US
James W. Broderick(Executive Officer, Director)John Hennessy(Executive Officer)Karen Hong(Director)James Lee(Director)Stephen Hoffman(Director)
BoardJens Eckstein(Director)
Co-investorsSR One Capital ManagementBioHealth Innovation, Inc.Pfizer VenturesVertex Ventures HC
Tele911 connects patients on scene with board-certified emergency medicine physicians via telehealth, bridging the gap between a 911 call and the emergency department to triage cases and reduce unnecessary ambulance and ER use.
Digital HealthHealthtechPasadena, US
Ramon Lizardo(Executive Officer)inChristopher Maloney(Executive Officer, Director, Promoter)Marc Eckstein(Executive Officer, Director)
BoardJeff Trost(Director)inBruce Meadows(Director)
Co-investorsLaerdal Million Lives Fund
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
EvolveImmune Therapeutics HoldingArmaGenBE BiopharmaJuventas TherapeuticsKoneksa HealthMaia OncologyOrphoMedRedpin TherapeuticsRedwood Bioscience
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.